Cell responses regulated by early reorganization of actin cytoskeleton  by Papakonstanti, E.A. & Stournaras, C.
FEBS Letters 582 (2008) 2120–2127Minireview
Cell responses regulated by early reorganization of actin cytoskeleton
E.A. Papakonstanti*, C. Stournaras
Department of Biochemistry, Medical School, University of Crete, GR-71110, Heraklion-Voutes, Greece
Received 14 January 2008; accepted 21 February 2008
Available online 4 March 2008
Edited by Ulrike KutayAbstract Microﬁlaments exist in a dynamic equilibrium be-
tween monomeric and polymerized actin and the ratio of mono-
mers to polymeric forms is inﬂuenced by a variety of
extracellular stimuli. The polymerization, depolymerization
and redistribution of actin ﬁlaments are modulated by several ac-
tin-binding proteins, which are regulated by upstream signalling
molecules. Actin cytoskeleton is involved in diverse cellular func-
tions including migration, ion channels activity, secretion, apop-
tosis and cell survival. In this review we have outlined the role of
actin dynamics in representative cell functions induced by the
early response to extracellular stimuli.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Actin is an evolutionary conserved 42-kDa protein and one
of the major cytoskeletal components in eukaryotic cells. Actin
occurs in two forms, the globular or G-actin which polymer-
izes into the other form which is called ﬁlamentous or F-actin.
Filamentous actin can be found as bundles called stress ﬁbers
or as ﬁne network underneath the plasma membrane called
microﬁlaments. There is also a third ﬁlamentous structure
called contractile ring, which is critical for the separation of
a cell during cytokinesis. Each microﬁlament has two diﬀerent
ends, at which polymerization takes place at diﬀerent rates: a
fast growing or plus end and a slow-growing or minus end.
In cells the plus end of the ﬁlaments is oriented towards the cell
membrane while the minus end towards the cytoplasm [1,2].
The association of microﬁlaments with cell membrane plays
a fundamental role in anchoring membrane proteins whereas
stress ﬁbers maintain the connections between the cell and
the surface on which it grows.
The relative proportion of F- and G-actin is determined by
the concentration of monomeric actin protein. At a critical
concentration of G-actin, the plus end of the microﬁlament
will constantly grow while the minus end simultaneously de-
cays thus the length of microﬁlament remains constant (tread-Abbreviations: TNFa, tumor necrosis factor-a; GPCRs, G-protein
coupled receptors.
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doi:10.1016/j.febslet.2008.02.064mill) [3,4]. The polymerization state of actin, the length of
microﬁlaments and their properties in the cells are regulated
by the actin-binding or actin-associated proteins. There are
numerous functionally important actin – associated pro-
teins[5]. Their binding to G- or F-actin has various functions:
they serve to control the length of ﬁlaments or to keep the ﬁl-
aments at a certain length (e.g. villin, coﬁlin, gelsolin, fragmin,
and severin), to produce bundles of actin ﬁlaments (e.g. villin,
ﬁlamin, and ﬁmbrin), to cross-link actin ﬁlaments forming a
meshwork such as that found in association with the cell mem-
brane (e.g. ﬁbrin, vinculin, a-actinin, and talin) or to control
G-actin pool by preventing the polymerization of actin (e.g.
proﬁlin). A key regulator of a number of actin binding proteins
is the PI(4,5)P2, the concentration of which is altered by the
enzymes phospholipase C-gamma (PLC-c) and PI3-kinase:
PLC-c hydrolyzes PI(4,5)P2 into diagylglycerol and inositol-
3-phosphate whereas PI3-kinase phosphorylates PI(4,5)P2
producing PI(3,4,5)P3. The binding of proﬁlin, gelsolin, villin
and coﬁlin with PI(4,5)P2 is competitive with that of actin
whereas WASP, a-actinin, and vinculin require PI(4,5)P2 to
bind actin[6,7]. Additionally, an important type of actin-asso-
ciated protein is the family of myosins which convert chemical
energy to produce movement of actin ﬁlaments. The best char-
acterized myosin, myosin II, slides actin ﬁlaments past each
other either to power contraction of the contractile ring during
cytokinesis or to produce cell migration [8–10].
The cell can control the physical properties of the cytoplasm
and to respond to extracellular stimuli by modulating the state
of microﬁlament network. The polymerization/depolymeriza-
tion of actin ﬁlaments is a dynamic process which is involved
and/or mediates various cell responses. In the present chapter
we summarize representative data showing the role of early ac-
tin cytoskeleton reorganization in the modulation of various
cell responses (Fig. 1).2. Actin cytoskeleton in the regulation of cell migration-invasion
The role of actin ﬁlaments in cell migration and invasion has
been extensively studied. Since the discovery of the Rho-family
of small GTPases [11,12] a lot of data has been accumulated
showing how these proteins regulate the actin cytoskeleton
during cell movement. Actin polymerization or depolymeriza-
tion is induced by an extracellular or intracellular signal that
activates members of the Rho-family. The mechanisms by
which Rho-family proteins aﬀect the dynamics of actin ﬁla-
ments and migration are complex [13–18] however, a simpliﬁed
model is that Rac proteins are involved in lamellipodia forma-
tion: Cdc42 in ﬁlopodia formation and Rho in stress ﬁbersblished by Elsevier B.V. All rights reserved.
Fig. 1. Transmission of signals to actin cytoskeleton triggers a variety
of cell responses. A signal is created by activation of membrane
receptors such as ion channel-linked receptors, GPCRs, TNF receptor,
and membrane-androgen receptors. Signal transduction molecules
relay the signal to the actin cytoskeleton. Alterations of actin
polymerization/depolymerization state have been implicated in various
cell responses including cell survival, proliferation, apoptosis, motility,
and secretion.
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regulation of Rho activity has to be well deﬁned since elevated
Rho activity induces high levels of stress ﬁbers and substrate
adhesions preventing migration [14,16,22–25]. High cellular
levels of active Rac most often correlated with low levels of ac-
tive Rho, and vice versa [16,26,27] whereas p110d isoform of
PI3-kinase also keeps RhoA activity in the correct balance
for proper migration [28]. Lamellipodia are veil-like sheets
which contain branched and cross-linked actin ﬁlaments
whereas ﬁllopodia are ﬁnger-like structures that project
beyond the lamellipodium and contain bundles of actin ﬁla-
ments [5]. Membrane protrusions are formed because of rapid
actin ﬁlament elongation at the tip of the leading edge [29]. The
ADF/coﬁlin family of proteins, the N-WASP/Arp2/3 complex
and gelsolin play pivotal role in nucleation of actin and the
Arp2/3 complex and cortactin are important for the formation
of actin branches found in lamellipodia [30–33]. Proteins such
as villin, ﬁmbrin and fascin are involved in stabilizing the bun-
dles of actin ﬁlaments in ﬁllopodia [33–38]. Branched actin ﬁl-
aments also determine the formation of the characteristic
structures of invasive cells called invadopodia and podosomes
[39].Motility is an important cell function under normal or path-
ological conditions including formation of tissues, embryonic
development, immune response and cancer. Defects or muta-
tions in actin-binding proteins or in actin gene or in proteins
involved in the regulation of actin polymerization/depolymer-
ization dynamics have been considered to cause human disor-
ders [40]. The Wiskott Aldrich Syndrome, neural tube closure
defects and neutrophil dysfunction are some among other dis-
eases characterized by impaired cell motility related to defected
actin polymerization [41–44]. Although, malignancy-related
mutations in b-actin have been found in a limited number of
tumors [45,46], the defects in actin dynamics that have been
correlated with enhanced motility of tumor cells are caused
by misregulation of upstream signalling molecules such as
the Rho-GTPases, LIMK, and PAK, or altered expression
of certain actin-binding proteins including gelsolin, coﬁlin,
proﬁlin, and Arp2/3 [40,47–56].3. Actin cytoskeleton and ion channel activity
Epithelial cells show a well established polarized morphol-
ogy and its maintenance is highly dependant on actin cytoskel-
eton architecture [57,58]. Cell–cell and cell-extracellular matrix
interactions, and specialized adhesion complexes such as tight
junctions, adherens junctions and desmosomes establish the
polarized morphology of epithelial cells [59]. The plasma mem-
brane of epithelial cells consists of distinct domains as a result
of their polarization: the apical and basolateral membrane do-
mains which are essential for the absorptive and secretory
functions of those cells [60]. The activities of various transport
proteins, channels for ions or water have been shown to de-
pend on the extent of actin polymerization [61–65]. Epithelial
ion channels interact directly or indirectly with actin and this
serves to maintain the polarized transport of ion channels to
speciﬁc membrane domains and to regulate their activity [66].
Renal proximal tubule cells represent a characteristic type of
epithelial cells with complex structure that mirrors the variety
of physiological processes they perform. The cells forming the
proximal tubule possess a dense brush border on the luminal
surface which is formed by the microvilli of the cells [67].
The main cytoskeletal component of the brush border mem-
brane of renal proximal tubular epithelial cells is actin micro-
ﬁlaments. Renal microvilli contain bundles of microﬁlaments
as well as actin-binding proteins such as villin and ﬁbrin, which
are involved in stabilizing the actin ﬁlaments bundles, calmod-
ulin and its associated 110-kDa protein, that are involved in
the association of microﬁlaments with cell membrane [68].
Renal inorganic phosphate (Pi) reabsorption is performed
by proximal tubule cells and determines the Pi homeostasis
which is critical for normal cellular metabolism. Eighty percent
of the Pi in the glomerular inﬁltrate is reabsorbed by proximal
tubule cells upon physiological hormone levels and dietary
conditions [69–71]. Transepithelial transport of Pi is performed
by a Na/Pi cotransport system located in the apical membrane
of renal proximal tubule cells [69]. In an attempt to examine
factors that control Pi reabsorption induced by low extracellu-
lar Pi concentration we have previously found that the
polymerization state of actin plays a key role in this process.
Up-regulation of Na/Pi cotransport induced a signiﬁcant depo-
lymerization of actin ﬁlaments that was necessary for the Pi
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the uptake of Pi by proximal tubule cells [72]. Acute up-regu-
lation of the cotransport resulted in co-precipitation and colo-
calization of villin with short actin ﬁlaments and actin
monomers indicative of an induction of actin-severing activity
of villin. Indeed, villin was found to be implicated in a signal-
ling mechanism involving PLC-c1 and PI3-kinase which lead
to depolymerization of microﬁlaments upon Na/Pi cotransport
up-regulation [73] giving insight in the mechanism that regu-
lates this physiologically important cell function.4. Actin cytoskeleton reorganization as a mediator and/or
eﬀector in membrane receptor signalling
Activation of cell membrane receptors including tyrosine ki-
nase receptors, G-protein coupled receptors (GPCRs), and
TNF receptor1 results in a cascade of intracellular signalling
events in which most often actin cytoskeleton is involved, lead-
ing to various cell responses that are correlated with normal
cellular functions or cell disorders. Several cell surface recep-
tors-triggered signalling pathways involve the activation of
PI3-kinase and the production of the lipid second messengers
PI(3,4,5)P3 and PI(3,4)P2 which then activate downstream
molecules such as Akt [74] relaying the signal. In addition,
Rho family GTPases and their downstream targets link plasma
membrane receptors signalling to organization of actin cyto-
skeleton induced by various stimuli [13,75–77].5. GPCR ligand-induced signalling
GPCRs have been considered as a promising target for ther-
apeutic drugsdevelopment since their activation by agonistic li-
gands regulates important cell functions and is also implicated
in abnormal processes including smooth muscle and cardiac
contraction, ﬂuid homeostasis, pain transmission, blood pres-
sure, secretion, cell migration and proliferation, tumorigenesis,
asthma, and inﬂammation [78–84]. The role of GPCRs in all
those cell responses makes necessary the elucidation of the sig-
nalling mechanisms that mediate their biological eﬀects. A lot
of knowledge has been accumulated showing that GPCRs sig-
nalling goes through Ca2+ and PKC, ERK, EGFR transacti-
vation and mTOR/p70S6K activation. The signalling
mechanisms leading to alterations of actin dynamics induced
by various heptahellical receptors has also been examined by
focusing on the Rho and FAK activation [85–87].
It has been shown that the GPCR agonists bombesin and
LPA stimulate the formation of stress ﬁbers in Swiss 3T3 cells
by their eﬀect on Rho and Rac [11,12]. In cases of GPCR-in-
duced Rho response, the Ga12/Ga13 subunits interact with
RhoGEFs, including p115RhoGEF, PDZ-RhoGEF and
leukemia-associated RhoGEF, leading to Rho activation
[86,88–91]. Rho activation is also induced by Gq/G11 via the
GEF protein LARG but with lower potency [92] whereas the
p63RhoGEF selectively activates RhoA via Gq [93]. Following
the activation of Rho, its downstream eﬀector ROCK is acti-
vated leading to phosphorylation and inhibition of myosin-
associated MLC phosphatase and thus to increased MLC
phosphorylation resulting in formation of stress ﬁbers, focal
adhesions assembly and FAK autophosphorylation at Tyr-397 which is a binding site for Src, PI3-kinase and PLC-c
[16,87,94]. A variety of GPCR agonists induce the phosphory-
lation of FAK at tyrosine and serine residues regulating migra-
tion and proliferation [87,95,96]. Phosphorylation of FAK at
serine residues is mediated by the Gq-induced activation of
PLC and the subsequent activation of ERK at Ser-910
[97,98] or by Ca2+/calmodulin-dependent kinase II at Ser-843
[99]. FAK phosphorylation at Ser-843 has been shown to inﬂu-
ence tyrosine phosphorylation and cell spreading and migra-
tion [100].
GPCR activation has also been linked with the reorganiza-
tion of the actin cytoskeleton via ezrin–radixin–moesin
(ERM) phosphorylation [101]. In this study, the G-protein
coupled receptor kinase 2 (GRK2) was found to transduse
the GPCRs-mediated signal to actin ﬁlaments by phosphory-
lating ERM after activation of muscarinic M1 receptor
(M1MR) in HepG2 cells.
Opioids belong to the superfamily of GPCR receptors [102]
and have been implicated in the modulation of cell proliferation
in a range of diﬀerent cell systems and of water excretion but
not of sodium or potassium handling in renal cells [103–106].
Opioid receptors have been categorized in three distinct types:
delta, mu, and kappa the latter subdivided in the subtypes k1,
k2, and k3 [107]. We have previously used a well-characterized
renal tubular cell line (OK cells) as a model to investigate the
signalling mechanism induced by these type of neuropeptides
leading to actin cytoskeleton reorganization. We have identi-
ﬁed k1-opioid binding sites in these cells [104] and a signiﬁcant
actin reorganization following their stimulation by the opioid
agonists as 1-casomorphin and ethylketocyclazosine [108].
Investigating the signalling mechanism that regulates the actin
redistribution, we found new mechanistic insights concerning
the transmission of the extracellular signal to the actin cytoskel-
eton. In response to those opioid agonists PAK1 was found to
be activated by a PI3-kinase-dependent but Cdc42/Rac1-inde-
pentent mechanism and to associate with the p85 subunit of
PI3-kinase only when the latter was activated. The fact that
PI3-kinase bound to the Cdc42/Rac1 binding-deﬁcient
PAK1(H83,86L) indicated that PI3-kinase–PAK1 association
does not involve the small GTPases. However, the potential
involvement of other proteins in PAK1–PI3-kinase interaction
cannot be excluded. The activation of PI3-kinase, but not of
Cdc42 or Rac1, was found to be essential for PAK1 activation
and PI3-kinase–PAK1 interaction [109]. We also obtained evi-
dence that actin can be phosphorylated in a PAK1-dependent
manner since the kinase-dead PAK1(K299R), or the PAK1
autoinhibitory domain (PAK1(83-149)), blocked its phosphor-
ylation [109]. This signalling mechanism was found to be active
during the early response to opioid agonists and for the time
periods where actin ﬁlament depolymerization was detected.
At later time points, the PI3-kinase–PAK1 association and
the actin phosphorylation discontinued while the activity of
RhoA and LIMK and the phosphorylation of coﬁlin were
gradually increased. At the same time actin started to re-poly-
merize forming new stress ﬁbers [109].6. TNFa-induced signalling
Tumor necrosis factor-a (TNFa) is a pleitropic cytokine: it
induces necrosis or apoptosis or elicits anti-apoptotic signals,
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sponse [110–112]. Key signalling molecules and Rho GTPases-
induced actin redistribution have been implicated in TNFa-
triggered signal transduction pathways [113–118].
An important role of TNFa in barrier function of epithelial
and endothelial cells has been described. The intestinal and re-
nal epithelial cells form a barrier between separate body com-
partments but allow nutrient and water absorption in the
intestines, and active and passive transport of various sub-
stances regulating urine composition in the kidney. Many
inﬂammatory bowel diseases are associated with loss of intes-
tinal barrier function and TNFa has been implicated in the
pathogenesis of these diseases [119–122]. The cytoskeletal reg-
ulation of barrier function plays a critical role, especially for
the maintenance of an intact paracellular space, which is di-
rectly related with intact epithelial tight junctions. It has been
shown that depolymerization of actin ﬁlaments results in dis-
ruption of tight junctions and in barrier disfunction by a mech-
anism involving caveolae-mediated occludin endocytosis which
is mediated by actin depolymerization [123–125]. TNFa has
been shown to induce barrier loss [126,127] by inducing epithe-
lial cells apoptosis [128], by non-apoptotic mechanisms [129],
or by reducing the transcription of tight junction proteins
[130]. In cultured intestinal epithelial cells, TNFa disrupted
barrier function via its eﬀect on MLC phosphorylation leading
to cytoskeletal contraction [131]. This intestinal barrier dys-
function was mediated by the induction of MLCK protein
expression by TNFa [132,133].
It has been shown that TNFa induces the formation of
membrane ruﬄes, ﬁllopodia, actin stress ﬁbers and intercellu-
lar gaps in endothelial cells [117]. An early response of these
cells to TNFa is characterized by increased activity of RhoA,
ROCK, and MLC phosphorylation while actin stress ﬁbers
redistribution and increased permeability was observed after
longer stimulation with TNFa [134]. In these cells, ROCK
but not MLCK contributed to stress ﬁber reorganization
whereas permeability was found to be independent of contrac-
tile mechanisms mediated by ROCK or MLCK and was corre-
lated with loss of proteins, such as occludin and JAM-A from
tight junctions [134]. In another study, TNFa-induced endo-
thelial cell permeability has been correlated with PAK activa-
tion, MLC phosphorylation and the formation of actin stress
ﬁbers [114].
Renal proximal tubular epithelial cells are targeted in a vari-
ety of immune and inﬂammatory diseases of the kidney, and
the role of inﬂammatory cytokines in the pathogenesis of renal
diseases has been established [135–138]. We have found that
TNFa exerts anti-apoptotic eﬀects in these cells and that the
polymerization state of actin plays a major role in the
TNFa-induced cell survival of proximal tubule cells [139]. In
that study we showed that TNFa induced a clear redistribution
of actin ﬁlaments including the dissolution of stress ﬁbers and
formation of peripheral ﬁllopodia, microspikes and intense
lamellipodia. The TNFa-mediated signalling cascade upstream
of actin involved the activation of PI3-kinase, the small GTP-
ases Cdc42/Rac1, and the phospholipase Cc1 (PLC-c1). Apart
from the role of Cdc42 in morphological changes observed it
was found to be essential for the activation of PLC-c1. In addi-
tion, actin depolymerization was found to play a central role in
the anti-apoptotic response of these cells to TNFa since stabil-
ization of actin ﬁlaments prevented the nuclear translocationof NF-jB, its binding activity and the subsequent inhibition
of caspase-3 [139].7. Membrane-steroid receptor-induced signalling
Actin polymerization and reorganization of actin ﬁlaments
have been also shown to play a central role in early cell re-
sponses induced by steroid hormones [140,141]. In recent
years, data has been accumulated showing that steroids stimu-
late rapid cellular responses [142–144] by a mechanism that do
not involve the classical nuclear receptors [145–147].
We have identiﬁed androgen-speciﬁc membrane binding
sites in intracellular-androgen receptor positive, LNCaP
[148], and in intracellular-androgen receptor deﬁcient,
DU145 [149], human prostate cancer cell lines. Activation of
this membrane receptor with non-cell permeable testosterone
conjugates induced apoptosis of either hormone-sensitive
LNCaP or hormone-insensitive DU145 cells and regression
of prostate cancer cells both, in vitro and in vivo [149,150].
Apoptotic cell death has also been associated with activation
of membrane testosterone receptors in primary cortical astro-
cytes [151] Prolonged exposure of LNCaP or DU145 cells to
these testosterone conjugates induced the depolymerization
of actin ﬁlaments and their redistribution to cell periphery
while also enhancing the pro-apoptotic and anti-proliferative
eﬀect of the microtubule-acting drug paclitaxel in vitro and
in vivo [150]. On the other hand, short-term stimulation of
membrane-testosterone receptors in LNCaP cells lead to actin
polymerization and to increased secretion of the prostate-spe-
ciﬁc antigen (PSA) which was prevented by actin ﬁlaments dis-
rupting agents [148]. We found that the non-genomic
testosterone-induced signalling pathway that lead to changes
in the ﬁlamentous actin and PSA secretion was governed by
FAK, PI3-kinase and the small GTPases Rac1 and Cdc42
[152]. By these studies we gave insight in the signalling mech-
anisms induced by membrane-steroid receptors and leading
to early cell responses. These ﬁndings collectively suggest that
mAR activation may be an important target for the apoptotic
regression of a certain cell or tissue.References
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